Outset Medical ROE 2019-2024 | OM

Current and historical return on equity (ROE) values for Outset Medical (OM) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Outset Medical ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-09-30 $-0.14B $0.05B -169.37%
2024-06-30 $-0.16B $0.07B -145.54%
2024-03-31 $-0.17B $0.09B -122.69%
2023-12-31 $-0.17B $0.12B -102.67%
2023-09-30 $-0.18B $0.15B -87.83%
2023-06-30 $-0.17B $0.18B -73.59%
2023-03-31 $-0.17B $0.22B -64.70%
2022-12-31 $-0.16B $0.25B -55.25%
2022-09-30 $-0.16B $0.28B -49.85%
2022-06-30 $-0.15B $0.31B -42.25%
2022-03-31 $-0.14B $0.35B -35.38%
2021-12-31 $-0.13B $0.37B -34.43%
2021-09-30 $-0.10B $0.41B -28.17%
2021-06-30 $-0.12B $0.43B -32.65%
2021-03-31 $-0.11B $0.31B -45.66%
2020-12-31 $-0.08B $0.33B -46.85%
2020-06-30 $-0.04B $0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.044B $0.130B
Outset Medical Inc. is a medical technology company. Its Tablo(R) Hemodialysis System represents technological advancement enabling novel, transformational dialysis care in acute and home settings. Outset Medical Inc. is based in CA, United States.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $9.226B 0.00
Inspire Medical Systems (INSP) United States $5.656B 176.38
Hims & Hers Health (HIMS) United States $5.534B 140.72
Enovis (ENOV) United States $2.608B 17.68
Privia Health (PRVA) United States $2.587B 215.60
IRhythm Technologies (IRTC) United States $2.316B 0.00
Azenta (AZTA) United States $2.209B 110.15
Omnicell (OMCL) United States $2.116B 69.23
10x Genomics (TXG) United States $1.732B 0.00
Clover Health Investments (CLOV) United States $1.689B 0.00
Schrodinger (SDGR) United States $1.518B 0.00
Phreesia (PHR) United States $1.148B 0.00
Butterfly Network (BFLY) United States $0.690B 0.00
Standard BioTools (LAB) United States $0.596B 0.00
Talkspace (TALK) United States $0.583B 0.00
Fulgent Genetics (FLGT) United States $0.547B 0.00
Definitive Healthcare (DH) United States $0.505B 87.40
Health Catalyst (HCAT) United States $0.495B 0.00
Pulmonx (LUNG) United States $0.268B 0.00
TruBridge (TBRG) United States $0.247B 71.91
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
American Well (AMWL) United States $0.124B 0.00
EUDA Health Holdings (EUDA) Singapore $0.112B 0.00
P3 Health Partners (PIII) United States $0.076B 0.00
HeartBeam (BEAT) United States $0.074B 0.00
111 (YI) China $0.052B 0.00
CareCloud (CCLD) United States $0.046B 0.00
SHL Telemedicine (SHLT) Israel $0.042B 0.00
Zepp Health (ZEPP) China $0.037B 0.00
Movano (MOVE) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Streamline Health Solutions (STRM) United States $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
MSP Recovery (LIFW) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00